Trustwise Launches the First Trust Layer for Agentic & Generative AI    -    LEARN MORE
Trustwise Launches the First Trust Layer for Agentic & Generative AI    -    LEARN MORE
Skip to main content

Artificial Intelligence Problems in Pharmaceuticals | Technology

AI Security

AI Security and Compliance in Pharmaceuticals

In the fast-evolving landscape of artificial intelligence (AI), the challenges of trust, control, and security have become critical barriers to achieving widespread adoption. Chief Technical Officers at large pharmaceutical companies are acutely aware of the need to navigate the complexities of AI systems while ensuring trust and security. Trustwise delivers an AI Security and Control Layer, including AI Trust Management for Agentic AI Systems, to address these pressing concerns. Modern AI projects often encounter issues related to unreliability, inefficiency, and lack of control, hindering their scalability despite ambitious goals. The emergence of agentic AI further exacerbates these challenges, introducing greater complexity and risk. This is the Trust Gap, a significant obstacle that must be overcome to foster confidence in AI adoption. Trustwise’s innovative solutions, such as Harmony Ai, are designed to minimize the Trust Gap throughout the entire AI lifecycle, encompassing simulation, verification, optimization, and governance.

The Trust Gap

The Trust Gap represents a critical barrier that impedes the seamless adoption and integration of AI solutions within large organizations. It encompasses the challenges associated with reliability, efficiency, and control, which are essential for the successful implementation of AI projects. The advent of agentic AI further complicates this landscape, creating additional layers of complexity and risk. Understanding and bridging the Trust Gap is essential for CTOs aiming to harness the full potential of AI while maintaining trust and security.

Trustwise’s Approach: Minimizing the Trust Gap

Trustwise’s approach revolves around embedding real-time security, control, and alignment into every AI agent, ensuring that innovation can scale without compromising control. Through this approach, Trustwise transforms naked agents into Shielded Agents, equipped with robust security measures to mitigate potential risks. Additionally, the company offers trust-as-code solutions through APIs, SDKs, MCPs, and Guardian Agents, providing tailored security and control options based on the specific needs of organizations. By integrating these solutions, CTOs can effectively mitigate the challenges posed by the Trust Gap, fostering a more secure and controlled AI environment.

Scheduling a Demo

We understand the importance of firsthand experience when considering innovative solutions for AI trust and security. To explore how Trustwise’s offerings can revolutionize your organization’s approach to AI, schedule a demo with us today.

In summary, Trustwise’s AI Security and Control Layer, coupled with AI Trust Management for Agentic AI Systems, offers a comprehensive solution to the challenges faced by CTOs in large pharmaceutical companies. By minimizing the Trust Gap and empowering organizations with robust security and control measures, Trustwise paves the way for the widespread adoption of AI with confidence and assurance.